These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
519 related articles for article (PubMed ID: 28951916)
21. Near-infrared-emitting heteroleptic cationic iridium complexes derived from 2,3-diphenylbenzo[g]quinoxaline as in vitro theranostic photodynamic therapy agents. Wang L; Yin H; Cui P; Hetu M; Wang C; Monro S; Schaller RD; Cameron CG; Liu B; Kilina S; McFarland SA; Sun W Dalton Trans; 2017 Jun; 46(25):8091-8103. PubMed ID: 28604869 [TBL] [Abstract][Full Text] [Related]
22. Cyclometalated iridium(III) tetrazine complexes for mitochondria-targeted two-photon photodynamic therapy. Tan Z; Lin M; Liu J; Wu H; Chao H Dalton Trans; 2024 Aug; 53(31):12917-12926. PubMed ID: 39028267 [TBL] [Abstract][Full Text] [Related]
23. Cyclometalated Iridium(III) Complexes as High-Sensitivity Two-Photon Excited Mitochondria Dyes and Near-Infrared Photodynamic Therapy Agents. Bi XD; Yang R; Zhou YC; Chen D; Li GK; Guo YX; Wang MF; Liu D; Gao F Inorg Chem; 2020 Oct; 59(20):14920-14931. PubMed ID: 32951429 [TBL] [Abstract][Full Text] [Related]
24. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086 [TBL] [Abstract][Full Text] [Related]
25. Long-wavelength triggered iridium(III) complex nanoparticles for photodynamic therapy against hypoxic cancer. Liu S; Wang Z; Wu Z; Chen H; Zhu D; Li G; Yan M; Bryce MR; Chang Y Chem Commun (Camb); 2024 Sep; 60(73):9938-9941. PubMed ID: 39171567 [TBL] [Abstract][Full Text] [Related]
26. Nucleus-Targeted Organoiridium-Albumin Conjugate for Photodynamic Cancer Therapy. Zhang P; Huang H; Banerjee S; Clarkson GJ; Ge C; Imberti C; Sadler PJ Angew Chem Int Ed Engl; 2019 Feb; 58(8):2350-2354. PubMed ID: 30552796 [TBL] [Abstract][Full Text] [Related]
27. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents. Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591 [TBL] [Abstract][Full Text] [Related]
28. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
29. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy. Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019 [TBL] [Abstract][Full Text] [Related]
30. X-ray tomography of cryopreserved human prostate cancer cells: mitochondrial targeting by an organoiridium photosensitiser. Bolitho EM; Sanchez-Cano C; Huang H; Hands-Portman I; Spink M; Quinn PD; Harkiolaki M; Sadler PJ J Biol Inorg Chem; 2020 Mar; 25(2):295-303. PubMed ID: 32124100 [TBL] [Abstract][Full Text] [Related]
31. Photoactivated Anticancer Activity of Cobalt(III) Complexes with Naturally Occurring Flavonoids Chrysin and Silibinin. Dutta J; Bera A; Upadhyay A; Yadav AK; Banerjee S; Sarkar T; Hussain A Chembiochem; 2024 Oct; 25(20):e202400484. PubMed ID: 38962951 [TBL] [Abstract][Full Text] [Related]
32. A Cyclometalated Ir Sudheesh KV; Jayaram PS; Samanta A; Bejoymohandas KS; Jayasree RS; Ajayaghosh A Chemistry; 2018 Aug; 24(43):10999-11007. PubMed ID: 29806867 [TBL] [Abstract][Full Text] [Related]
34. Photostable Iridium(III) Cyclometallated Complex is an Efficient Photosensitizer for Killing Multiple Cancer Cell Lines and 3D Models under Low Doses of Visible Light. Jones C; Martinez-Alonso M; Gagg H; Kirby L; Weinstein JA; Bryant HE J Med Chem; 2024 Sep; 67(18):16157-16164. PubMed ID: 39231957 [TBL] [Abstract][Full Text] [Related]
35. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro. Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525 [TBL] [Abstract][Full Text] [Related]
36. Trifluoromethyl-Substituted Iridium(III) Complexes: From Photophysics to Photooxidation of a Biological Target. Bevernaegie R; Marcélis L; Laramée-Milette B; De Winter J; Robeyns K; Gerbaux P; Hanan GS; Elias B Inorg Chem; 2018 Feb; 57(3):1356-1367. PubMed ID: 29336560 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of the Medicinal Potential of Two Ruthenium(II) Polypyridine Complexes as One- and Two-Photon Photodynamic Therapy Photosensitizers. Hess J; Huang H; Kaiser A; Pierroz V; Blacque O; Chao H; Gasser G Chemistry; 2017 Jul; 23(41):9888-9896. PubMed ID: 28509422 [TBL] [Abstract][Full Text] [Related]
38. π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy. Wang L; Yin H; Jabed MA; Hetu M; Wang C; Monro S; Zhu X; Kilina S; McFarland SA; Sun W Inorg Chem; 2017 Mar; 56(6):3245-3259. PubMed ID: 28263079 [TBL] [Abstract][Full Text] [Related]
39. Iridium(III) complexes as novel theranostic small molecules for medical diagnostics, precise imaging at a single cell level and targeted anticancer therapy. Szymaszek P; Tyszka-Czochara M; Ortyl J Eur J Med Chem; 2024 Oct; 276():116648. PubMed ID: 38968786 [TBL] [Abstract][Full Text] [Related]
40. Cyclometalated Iridium(III) Complexes as Mitochondria-targeting Photosensitizers against Cisplatin-resistant Cells. Xiong K; Zhou Y; Lin X; Kou J; Lin M; Guan R; Chen Y; Ji L; Chao H Photochem Photobiol; 2022 Jan; 98(1):85-91. PubMed ID: 33617666 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]